Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Phase 2
Active, not recruiting
- Conditions
- CholangiocarcinomaGastrointestinal CancersPancreatic Ductal AdenocarcinomaColorectal CancerHepatocellular CarcinomaGastric Cancer
- Interventions
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- SOFIE
- Target Recruit Count
- 120
- Registration Number
- NCT05641896
- Locations
- ๐บ๐ธ
University of California Los Angeles (UCLA) Health, Los Angeles, California, United States
๐บ๐ธMemorial Sloan Kettering Cancer Center (MSKCC), New York, New York, United States
๐บ๐ธMassachusetts general hospital, Boston, Massachusetts, United States
Study of [68Ga]FAPI-46 PET in Patients with Pancreatic Ductal Carcinoma
Phase 2
Active, not recruiting
- Conditions
- PDAC - Pancreatic Ductal AdenocarcinomaFAP
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- SOFIE
- Target Recruit Count
- 60
- Registration Number
- NCT05262855
- Locations
- ๐บ๐ธ
University of California Los Angeles (UCLA) Health, Los Angeles, California, United States
๐บ๐ธBAMF Health, Grand Rapids, Michigan, United States
๐บ๐ธMayo Clinic, Rochester, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath